Real-time enrollment status for this blood cancer clinical trial
Current Status
Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06533579 |
| Recruiting Status | Recruiting |
| Condition | Blood Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 32 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Vironexis Biotherapeutics Inc. |
| Last Updated on CT.gov | March 30, 2026 (2 weeks ago) |
As of April 18, 2026: Clinical trial NCT06533579 is currently recruiting participants. This clinical trial study for blood cancer is actively seeking new participants at 8 locations across the United States. The study is sponsored by Vironexis Biotherapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06533579 is actively recruiting participants as of April 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06533579 was last updated 2 weeks ago (March 30, 2026). HelloStudys verifies this status automatically.